tiprankstipranks
Alpine Immune Sciences, Truveta enter strategic partnership
The Fly

Alpine Immune Sciences, Truveta enter strategic partnership

Truveta and Alpine Immune Sciences announced a strategic partnership to help accelerate clinical trial recruitment for povetacicept, Alpine’s dual B cell cytokine antagonist being developed for multiple B cell-mediated autoimmune and inflammatory diseases. With this partnership, Alpine and Truveta will work to rapidly identify and recruit participants for Alpine’s RUBY clinical trial program for povetacicept, including the RUBY-3 study in autoimmune glomerulonephritis and RUBY-4 study in autoimmune cytopenias.

Published first on TheFly

See the top stocks recommended by analysts >>

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles